Tuesday, October 5, 2021
New Haven, CT (Oct. 5, 2021) – Greenwich Hospital announced that it has begun taking appointments for booster and dose three vaccinations at the hospital.
In accordance with The Centers for Disease Control and Prevention (CDC) and in partnership with Yale New Haven Health (YNHHS), Greenwich Hospital will administer booster doses of the Pfizer COVID-19 vaccine for long-term care residents and those 65 and older,18 to 64 with underlying conditions, and 18 and older at increased risk for COVID-19 exposure. Booster doses can be given six months after initial vaccine series. An explanation on the differences between a third dose and a booster can be found here. Those who received J&J or Moderna are not yet eligible for a booster.
In addition, CDC now recommends a third dose for patients who are immunocompromised and received either Pfizer or Moderna.
All vaccinations are by appointment only and can be made on the YNHHS website: www.ynhhs.org/covidvaccine. Individuals must wear a mask and answer screening questions upon arrival. More appointments will be added as the vaccine becomes available to ensure a sufficient supply for all scheduled patients.
Greenwich Hospital is a member of Yale New Haven Health. Greenwich is a 206-bed community hospital serving lower Fairfield County, Connecticut and Westchester County, New York. It is an academic affiliate of Yale School of Medicine. Since opening in 1903, Greenwich Hospital has evolved into a progressive medical center and teaching institution representing all medical specialties and offering a wide range of medical, surgical, diagnostic and wellness programs. Greenwich Hospital is recognized throughout the healthcare industry as a leader in service and patient satisfaction excellence. Greenwich Hospital has the prestigious Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. www.greenwichhospital.org
9/9/2026
Yale New Haven Health Names Daniel del Portal, MD, MBA, Chief Clinical OfficerNEW HAVEN, Conn. (September 9, 2026) – Yale New Haven Health (YNHHS) today announced that Daniel del Portal, MD, MBA, has been named Executive Vice President and Chief Clinical Officer. In this role, Dr. del Portal will lead systemwide efforts to advance quality, safety, patient experience, clinical growth and operational performance across Yale New Haven Health.
9/1/2026
Hartford HealthCare and Yale New Haven Health Celebrate Grand Opening of Connecticut Proton CenterWALLINGFORD, CT (September 1, 2026) – Hartford HealthCare and Yale New Haven Health today celebrated the grand opening of the Connecticut Proton Center, marking a new era in cancer care and bringing the state's first proton beam therapy center to patients.
8/25/2026
Bridgeport Hospital Introduces Aquablation Therapy for Men with Enlarged ProstateBRIDGEPORT, CT (August 25, 2026) – Bridgeport Hospital is now offering Aquablation® therapy, an innovative, minimally invasive robotic-assisted procedure for men suffering from benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate. The first procedures were performed at Bridgeport Hospital following the program's launch in July 2026.
Tyler Landis
Media Coordinator
Public Relations
203-863-3463
Email